Unknown PHASE2 INTERVENTIONAL 2-arm NCT02456324

A Prospective European Post-Market Clinical Evaluation of the CuraSeal Percutaneous Intraluminal Closure System for Anorectal Fistulas

Sponsor: Curaseal Inc.

Conditions Anal Fistulas Rectal Fistulas

Interventions Historical Controls Treated with Commercially Available Fistula Plugs PICS-AF Device

Updated 6 times since 2017 Last updated: May 26, 2015 Started: May 31, 2015 Primary completion: May 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02456324, this PHASE2 trial focuses on Anal Fistulas and Rectal Fistulas and remains ongoing. Sponsored by Curaseal Inc., it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2017 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Recruiting PHASE2

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Curaseal Inc.

Data source: Curaseal Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seville, Spain